Real‐world experience of off‐label use of imiquimod 5% as an adjuvant therapy after surgery or as a monotherapy for lentigo maligna. (1st September 2021)

Record Type:: Journal Article
Title:: Real‐world experience of off‐label use of imiquimod 5% as an adjuvant therapy after surgery or as a monotherapy for lentigo maligna. (1st September 2021)
Main Title:: Real‐world experience of off‐label use of imiquimod 5% as an adjuvant therapy after surgery or as a monotherapy for lentigo maligna
Authors:: Lallas, A.
Moscarella, E.
Kittler, H.
Longo, C.
Thomas, L.
Zalaudek, I.
Kyrgidis, A.
Manoli, S.M.
di Meo, N.
Papageorgiou, C.
Apalla, Z.
Argenziano, G.
Abstract:
Is Part Of:: British journal of dermatology. Volume 185:Number 3(2021)
Journal:: British journal of dermatology
Issue:: Volume 185:Number 3(2021)
Issue Display:: Volume 185, Issue 3 (2021)
Year:: 2021
Volume:: 185
Issue:: 3
Issue Sort Value:: 2021-0185-0003-0000
Page Start:: 675
Page End:: 677
Publication Date:: 2021-09-01
Subjects:: Dermatology -- Periodicals
Skin -- Diseases -- Periodicals
616.5
Journal URLs:: http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2133 ↗
https://academic.oup.com/bjd ↗
http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1111/bjd.20407 ↗
Languages:: English
ISSNs:: 0007-0963
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 2307.400000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 24866.xml